Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Operating Leases: 2022-2024

Historic Operating Leases for Gossamer Bio (GOSS) over the last 3 years, with Dec 2024 value amounting to $4.4 million.

  • Gossamer Bio's Operating Leases fell 27.16% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year decrease of 27.16%. This contributed to the annual value of $4.4 million for FY2024, which is 2954.17% up from last year.
  • Per Gossamer Bio's latest filing, its Operating Leases stood at $4.4 million for FY2024, which was up 2,954.17% from $144,000 recorded in FY2023.
  • In the past 5 years, Gossamer Bio's Operating Leases registered a high of $4.4 million during FY2024, and its lowest value of $144,000 during FY2023.
  • Its 3-year average for Operating Leases is $2.7 million, with a median of $3.4 million in 2022.
  • Per our database at Business Quant, Gossamer Bio's Operating Leases plummeted by 95.82% in 2023 and then spiked by 2,954.17% in 2024.
  • Gossamer Bio's Operating Leases (Yearly) stood at $3.4 million in 2022, then tumbled by 95.82% to $144,000 in 2023, then soared by 2,954.17% to $4.4 million in 2024.